4,6-Dibromoisophthalic acid, 97%, 5g

1-Methyl-3,5-dinitro-2-pyridone>98.0%(GC)1g

2-Methyl-4-phenylbutanoic acid, 97%, 250mg

3H-Oxazolo[4,5-b]pyridin-2-one, 97.0%, 100g

3-Bromobenzohydrazide>98.0%(GC)(T)1g

(5-Methoxypyrimidin-2-yl)methanamine dihydrochloride, 250mg

Cyclohexane, min 99.5%, pour synthèse, 2.5L, conditionnement verre

N-FMOC-L-Statine, 95.0%, 5g

2-(3-Bromo-phenoxy)-ethylamine, 95.0%, 1g

1-(2-Chloro-3-methyl-4-(methylsulfonyl)phenyl)ethanone, 95%, 250mg

3-(3-Methoxypropoxy)benzenamine, 95+%, 250mg

4-Butyl-4'-((4-butyl-2,6-difluorophenyl)ethynyl)-1,1'-biphenyl, 98%, 500mg

4,4,5,5-TETRAMETHYL-2-(10-PHENYLANTHRACEN-9-YL)-1,3,2-DIOXABOROLANE, 95.0%, 25g